Lactobacillus Bacteremia, Clinical Significance, and Patient Outcome, with Special Focus on Probiotic L. Rhamnosus GG
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Lactobacillus bacteremia is a rare entity, and its clinical significance is poorly defined. We have reviewed the risk factors and outcome for 89 case patients with Lactobacillus bacteremia. Species characterization was done in 53% of the cases, revealing 25 L. rhamnosus strains and 22 other Lactobacillus species. In 11 cases, the strain was identical with the probiotic L. rhamnosus GG. In 82% of the cases, the patients had severe or fatal comorbidities. Predisposing factors to bacteremia were immunosuppression, prior prolonged hospitalization, and prior surgical interventions. No significant differences were observed in these predisposing factors or clinical features between patients with cases associated with the various Lactobacillus species, other than higher C-reactive protein values in patients with L. rhamnosus bacteremia. Mortality was 26% at 1 month and was 48% at 1 year. In multivariate analysis, severe underlying diseases were a significant predictor for mortality (odds ratio [OR], 15.8), whereas treatment with antimicrobials effective in vitro was associated with lower mortality (OR, 0.22). We conclude that lactobacilli in blood cultures are of clinical significance and that their susceptibility should guide decisions about antimicrobial treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The source of these infections has sometimes been attributed to the use of Lactobacillus-containing probiotics [9,10,11].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
In the citing paper
“In contrast, treatment with antibiotics effective in vitro was associated with lower mortality (OR = 0.22) [9].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
In the citing paper
“Salminen et al. reviewed the risk factors and outcomes for LB using multivariate analysis and found severe underlying diseases, which were primarily malignancies or serious gastrointestinal disorders, and were a significant predictor for mortality (odds ratio [OR] = 15.8).”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
In the citing paper
“In 82% of the cases, the patients had severe or fatal comorbidities.”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
In the citing paper
“LB is usually associated with patients who have comorbidities or suppressed immune systems [6,7,9,28,29,30].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [9]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Gram-Negative Bacteremia: I. Etiology and Ecology
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240029006 · Cited by 1,362
Walter, J., Tannock, G. W., Tilsala-Timisjarvi, A., Rodtong, S., Loach, D. M., Munro, K., & Alatossava, T. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.1.297-303.2000 · Cited by 607 · cited 1×
“casei [15], Lactobacillus fermentum [16], Lactobacillus gasseri, and Lactobacillus zeae [17] were performed to identify the strains.”
BackgroundAntibacterial susceptibility tests : Dilution and disk diffusion methods.
Woods, G. (1995) · Medical Entomology and Zoology · Cited by 556
Lactic acid bacteria and human clinical infection
Aguirre, M., & Collins, M. D. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb02753.x · Cited by 425 · cited 2×
“they have been regarded as contaminants [1].”
BackgroundSalminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., & Järvinen, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342912 · Cited by 419 · cited 6×
“rhamnosus species–specific PCR used, and typing by PFGE have been described elsewhere [11].”
BackgroundMethodInfluentialSelf-citationLiver Abscess Due to a Lactobacillus rhamnosus Strain Indistinguishable from L. rhamnosus Strain GG
Rautio, M., Jousimies‐Somer, H., Kauma, H., Pietarinen, I., Saxelin, M., Tynkkynen, S., & Koskela, M. (1999) · Clinical Infectious Diseases · doi:10.1086/514766 · Cited by 327
Self-citationSong, Y. (2000) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(00)00196-8 · Cited by 313 · cited 1×
“casei [15], Lactobacillus fermentum [16], Lactobacillus gasseri, and Lactobacillus zeae [17] were performed to identify the strains.”
BackgroundLactobacillus bacteremia and endocarditis: Review of 45 cases
Husni, R. N., Gordon, S. M., Washington, J. A., & Longworth, D. L. (1997) · Clinical Infectious Diseases · doi:10.1086/516109 · Cited by 270 · cited 7×
“The majority of Lactobacillus bacteremia cases occurred within 48 h after hospitalization, whereas most cases have previously been reported to be nosocomial [2].”
BackgroundResultInfluentialLactobacillus endocarditis caused by a probiotic organism
Mackay, A. D., Taylor, M. B., Kibbler, C. C., & Hamilton-Miller, J. M. T. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00144.x · Cited by 264
Research works printed but not linked: 4
- Song YL, 2000, FEMS Microbiol Lett, 187, 167
- Jorgensen JH, 1999, Washington DC: American Society for Microbiology, 1526
- Durack DT, 1994, Duke Endocarditis Service. Am J Med, 96, 200
- Gasser F, 1994, Bull Inst Pasteur, 92, 45
Cited by
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Doron, S., & Snydman, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ085 · Cited by 942
“blood appeared identical to the probiotic strain LGG by pulse field gel electrophoresis [69]; however, in a subsequent study, the LGG-like isolates from the blood cultures were found to be phenotypically different from probiotic LGG [70] when subject-”
BackgroundMcFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 607
Williams, N. T. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090168 · Cited by 517
Lin, H.-C., Hsu, C.-H., Chen, H.-L., Chung, M.-Y., Hsu, J.-F., Lien, R.-I., Tsao, L.-Y., Chen, C.-H., & Su, B.-H. (2008) · Pediatrics · doi:10.1542/peds.2007-3007 · Cited by 506
(EFSA), E. F. S. A. (2007) · EFSA Journal · doi:10.2903/j.efsa.2007.587 · Cited by 479
Pathogenic relevance of Lactobacillus: A retrospective review of over 200 cases
Cannon, J. P., Lee, T. A., Bolanos, J. T., & Danziger, L. H. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1253-y · Cited by 478
Pathogenic Gut Flora in Patients With Chronic Heart Failure
Pasini, E., Aquilani, R., Testa, C., Baiardi, P., Angioletti, S., Boschi, F., Verri, M., & Dioguardi, F. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.10.009 · Cited by 436
“At least in intensive care, there have been reported cases of bacteremia in patients taking probiotics (35) or in patients neighboring those who were administered probiotics (36).”
BackgroundStrategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
Klompas, M., Branson, R., Eichenwald, E. C., Greene, L. R., Howell, M. D., Lee, G., Magill, S. S., Maragakis, L. L., Priebe, G. P., Speck, K., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/677144 · Cited by 427
Probiotics and Prebiotics in Pediatrics
Thomas, D. W., Greer, F. R., & Committee on Nutrition; Section on Gastroenterology, H. (2010) · Pediatrics · doi:10.1542/peds.2010-2548 · Cited by 415
Klompas, M., Branson, R., Cawcutt, K., Crist, M., Eichenwald, E. C., Greene, L. R., Lee, G., Maragakis, L. L., Powell, K., Priebe, G. P., et al. (2022) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2022.88 · Cited by 402
Österlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., Kouri, M., Elomaa, I., & Joensuu, H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603990 · Cited by 405
Self-citationLactobacillus species: Taxonomic complexity and controversial susceptibilities
Goldstein, E. J. C., Tyrrell, K. L., & Citron, D. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ072 · Cited by 392
“In 2004 Salminen, et al [30] reviewed 89 patients between 1990 and 2000 with Lactobacillus bacteremia, including L.”
BackgroundLactic Acid Bacteria: Food Safety and Human Health Applications
Ayivi, R. D., Gyawali, R., Krastanov, A., Aljaloud, S. O., Worku, M., Tahergorabi, R., Silva, R. C. D., & Ibrahim, S. A. (2020) · Dairy · doi:10.3390/dairy1030015 · Cited by 367
“rhamnosus (LGG) that has been classified as safe and has also been found to be an enhanced immune system booster, particularly in HIV-infected patients [160].”
BackgroundA systematic review of the safety of probiotics
Didari, T., Solki, S., Mozaffari, S., Nikfar, S., & Abdollahi, M. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.872627 · Cited by 367
“In this study, immune-deficient and post-surgical patients were suggested to be more at risk to sepsis [50].”
BackgroundInfluentialSnydman, D. R. (2008) · Clinical Infectious Diseases · doi:10.1086/523331 · Cited by 336
Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics
Quigley, E. M. M., & Quera, R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.046 · Cited by 329
Yelin, I., Flett, K. B., Merakou, C., Mehrotra, P., Stam, J., Snesrud, E., Hinkle, M., Lesho, E., McGann, P., McAdam, A. J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0626-9 · Cited by 315
Szajewska, H., Ruszczyński, M., & Radzikowski, A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.04.053 · Cited by 303
Treatment of Clostridium difficile Infection
Gerding, D. N., Muto, C. A., & Owens, Jr. (2008) · Clinical Infectious Diseases · doi:10.1086/521860 · Cited by 287
“boulardii in immunocompetent hosts and immunocompromised hosts [76-79].”
BackgroundDe Groote, M. A., Frank, D. N., Dowell, E., Glode, M. P., & Pace, N. R. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154588.79356.e6 · Cited by 284
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Guo, Q., Goldenberg, J. Z., Humphrey, C., El Dib, R., & Johnston, B. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub5 · Cited by 275
“…abscesses) resulting from probiotic use have been reported in neonates, severely debilitated and immuno-compromised individuals (Land 2005; Salminen 2004; Mackay 1999; Piarroux 1999; Rautio 1999; McFarland 1998; Salminen 1998; Saxelin 1996; Hata 1988; Sussman 1986), and there is still…”
BackgroundMechanisms and therapeutic effectiveness of lactobacilli
Di Cerbo, A., Palmieri, B., Aponte, M., Morales-Medina, J. C., & Iannitti, T. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-202976 · Cited by 266
Safety of probiotics: translocation and infection: Nutrition Reviews©, Vol. 66, No. 4
Liong, M.-T. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00024.x · Cited by 265
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Johnston, B. C., Goldenberg, J. Z., Vandvik, P. O., Sun, X., & Guyatt, G. H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub3 · Cited by 222
Johnstone, J., Meade, M., Lauzier, F., Marshall, J., Duan, E., Dionne, J., Arabi, Y. M., Heels-Ansdell, D., Thabane, L., Lamarche, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.13355 · Cited by 226
Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2006) · Clinical Infectious Diseases · doi:10.1086/500214 · Cited by 218
“Identification was confirmed by species-specific PCR or by partial sequencing of 16S rDNA, as described elsewhere [4, 19].”
BackgroundMethodInfluentialSelf-citationLactobacillus GG: Bacteriology and Clinical Applications
Doron, S., Snydman, D. R., & Gorbach, S. L. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.05.011 · Cited by 211
“Eleven of 89 Lactobacillus bacteremia isolates could not be distinguished from LGG by pulsed-field gel electrophoresis; however, despite increasing consumption of LGG, the rate of Lactobacillus bacteremia remained constant over time [15].”
BackgroundHungin, A. P. S., Mulligan, C., Pot, B., Whorwell, P., Agréus, L., Fracasso, P., Lionis, C., Mendive, J., Philippart de Foy, J.-M., Rubin, G., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12460 · Cited by 212
Prevention of infections by probiotics
Nomoto, K. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.100.583 · Cited by 208
Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies
Duan, H., Yu, L., Tian, F., Zhai, Q., Fan, L., & Chen, W. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1843396 · Cited by 207
Do probiotics offer opportunities to manipulate the periodontal oral microbiota?
Teughels, W., Loozen, G., & Quirynen, M. (2011) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01665.x · Cited by 204
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
Klompas, M., Branson, R., Eichenwald, E. C., Greene, L. R., Howell, M. D., Lee, G., Magill, S. S., L. Maragakis, L., P. Priebe, G., Speck, K., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1017/s0899823x00193894 · Cited by 196
Johnston, B. C. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051603 · Cited by 192
Probiotics: their role in the treatment and prevention of disease
Doron, S., & Gorbach, S. L. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.2.261 · Cited by 191
Iacono, A., Raso, G. M., Canani, R. B., Calignano, A., & Meli, R. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.002 · Cited by 192
“Saccharomyces cerevisiae fungemia [171] and Lactobacillus bacteremia [169,172] have been reported in patients with severe underlying illnesses.”
BackgroundShah, A. B., Baiseitova, A., Zahoor, M., Ahmad, I., Ikram, M., Bakhsh, A., Shah, M. A., Ali, I., Idress, M., Ullah, R., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2431643 · Cited by 185
Oral candidosis – Clinical challenges of a biofilm disease
Rautemaa, R., & Ramage, G. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.585606 · Cited by 188
“In immunocompromised patients, however, the damaged mucosa may act as a portal of entry for the probiotic micro-organism and result in bacteraemia and sepsis (Salminen et al., 2004).”
BackgroundBehzadi, E., Mahmoodzadeh Hosseini, H., & Imani Fooladi, A. A. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.06.016 · Cited by 182
Evidence-based guidelines for use of probiotics in preterm neonates
Deshpande, G. C., Rao, S. C., Keil, A. D., & Patole, S. K. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-92 · Cited by 166
“In the few published reports of bacteraemia with probiotics, there is scant detail about the blood culture manufacturer or system or the media used [103-106].”
BackgroundMethodProbiotics in Gastrointestinal Diseases in Children: Hard and Not‐So‐Hard Evidence of Efficacy
Szajewska, H., Setty, M., Mrukowicz, J., & Guandalini, S. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000221913.88511.72 · Cited by 164
“A recent report from Finland indicates that an increase in the use of LGG in food has not increased the incidence of Lactobacillus bacteremia or the overall incidence of bacteremia from any organism (156).”
BackgroundMeta‐analysis: probiotics in antibiotic‐associated diarrhoea
Videlock, E. J., & Cremonini, F. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05104.x · Cited by 158
Solieri, L., Bianchi, A., Mottolese, G., Lemmetti, F., & Giudici, P. (2013) · Food Microbiology · doi:10.1016/j.fm.2013.10.003 · Cited by 171
Lactobacillus Bacteremia and Probiotics: A Review
Kullar, R., Goldstein, E. J. C., Johnson, S., & McFarland, L. V. (2023) · Microorganisms · doi:10.3390/microorganisms11040896 · Cited by 156
“found that in patients with LB, the mortality was 26% at one month and 48% at one year [9].”
BackgroundInfluentialThe yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA
Surana, N. K., & Kasper, D. L. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01075.x · Cited by 170
“Use of whole organisms (even organisms typically found in the intestinal flora) as probiotics is occasionally associated with disease; thus attempts to alter the bowel flora must be undertaken with caution (123, 124).”
BackgroundReappraisal of probiotics’ safety in human
Sotoudegan, F., Daniali, M., Hassani, S., Nikfar, S., & Abdollahi, M. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.04.032 · Cited by 154
Are Probiotic Really Safe for Humans?
ZAWISTOWSKA-ROJEK, A., & TYSKI, S. (2018) · Polish Journal of Microbiology · doi:10.21307/pjm-2018-044 · Cited by 153
Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer
Banna, G. L., Torino, F., Marletta, F., Santagati, M., Salemi, R., Cannarozzo, E., Falzone, L., Ferraù, F., & Libra, M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00603 · Cited by 150
“…through several methods such as species-specific PCR, PFGE profiling of L. rhamnosus GG, bacteriophage typing, proteome analysis using 2D-DIGE and culture methods (i.e., using MRS growth agar medium) (Salminen et al., 2002, 2004, 2006; Koskenniemi et al., 2009; Villion and Moineau, 2009).”
MethodMantegazza, C., Molinari, P., D’Auria, E., Sonnino, M., Morelli, L., & Zuccotti, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.001 · Cited by 152
The Beneficial Role of Probiotic Lactobacillus in Respiratory Diseases
Du, T., Lei, A., Zhang, N., & Zhu, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908010 · Cited by 181
Unlocking the power of postbiotics: A revolutionary approach to nutrition for humans and animals
Zhao, X., Liu, S., Li, S., Jiang, W., Wang, J., Xiao, J., Chen, T., Ma, J., Khan, M. Z., Wang, W., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.004 · Cited by 160
Coppola, R., Succi, M., Tremonte, P., Reale, A., Salzano, G., & Sorrentino, E. (2005) · Le Lait · doi:10.1051/lait:2005007 · Cited by 174
Prospects for the development of probiotics and prebiotics for oral applications
DeVine, D., & Marsh, P. D. (2009) · Journal of Oral Microbiology · doi:10.3402/jom.v1i0.1949 · Cited by 161
“Other predisposing factors include prior prolonged hospitalisation and prior surgical intervention (124).”
BackgroundBtaiche, I. F., Chan, L., Pleva, M. R., & Kraft, M. D. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533609357565 · Cited by 133
Honeycutt, T., Khashab, M. E., Wardrop, R. M., McNeal-Trice, K. A., Honeycutt, A. L. B., Christy, C. G., Mistry, K. P., Harris, B. D., Meliones, J. N., & Kocis, K. C. (2007) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000282176.41134.e6 · Cited by 130
“In addition, two more pediatric case reports of Lactobacillus GG bacteremia during probiotic therapy were described in three patients with short gut syndrome requiring total parenteral nutrition (26, 27).”
BackgroundSelecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model
Daniel, C., Poiret, S., Goudercourt, D., Dennin, V., Leyer, G. J., & Pot, B. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.00109-06 · Cited by 145
“However, the possible involvement of certain LAB strains was described in cases of sepsis, endocarditis, or bacteremia, mostly in association with a severe underlying disease or detrimental condition (21, 35, 36).”
BackgroundRuszczyński, M., Radzikowski, A., & Szajewska, H. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03714.x · Cited by 147
Probiotics and gut health: A special focus on liver diseases
Gratz, S. W., Mykkanen, H., & El-Nezami, H. S. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i4.403 · Cited by 145
“Salminen et al [ 51 ] investigated the severity and outcome of lactobacillus bacteraemia in 89 patients, and report mortality of 26% 1 mo after illness onset, but only in patients with severe underlying comorbidities.”
BackgroundProbiotics for Prevention of Antibiotic-associated Diarrhea
Doron, S., Hibberd, P. L., & Gorbach, S. L. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181618ab7 · Cited by 133
Todorov, S. D., Popov, I. V., Weeks, R. M., & Chikindas, M. L. (2022) · Foods · doi:10.3390/foods11193145 · Cited by 143
Strain-Specific Effects of Probiotics on Gut Barrier Integrity following Hemorrhagic Shock
Luyer, M. D. P., Buurman, W. A., Hadfoune, M., Speelmans, G., Knol, J., Jacobs, J. A., Dejong, C. H. C., Vriesema, A. J. M., & Greve, J. W. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3686-3692.2005 · Cited by 134
“In a clinical setting, translocation of lactobacilli occurs rarely and is often regarded as harmless, although bacteremia with lactobacilli may be detrimental and requires specific antimicrobial treatment (34).”
BackgroundIs primary prevention of Clostridium difficile infection possible with specific probiotics?
Johnson, S., Maziade, P.-J., McFarland, L. V., Trick, W. E., Donskey, C. J., Currie, B. P., Low, D. E., & Goldstein, E. J. C. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.06.005 · Cited by 134
Defence factors of vaginal lactobacilli
Kovachev, S. M. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1306688 · Cited by 131
“…to extracellular matrix components stimulates plasminogen receptor expression, which may underlie LAB opportunistic infections (Styriak et al. 2003; Salminen et al. 2004); however, receptor binding does not always induce enzymatic cascade activity, but may prevent subsequent binding by pathogenic…”
BackgroundProbiotics for the prevention of pediatric antibiotic-associated diarrhea
Johnston, B. C., Supina, A. L., Ospina, M. B., & Vohra, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub2 · Cited by 130
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future
Andermann, T. M., Peled, J. U., Ho, C. M., Reddy, P. R., Riches, M., Storb, R. F., Teshima, T., van den Brink, M. R. M., Alousi, A. M., Balderman, S., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.02.009 · Cited by 116
Clinical Efficacy of Probiotics: Review of the Evidence With Focus on Children
Michail, S. K., Sylvester, F. A., Fuchs, G. J., & Issenman, R. M. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000239990.35517.bf · Cited by 136
Timmerman, H. M., Niers, L. E. M., Ridwan, B. U., Koning, C. J., Mulder, L. H. C., Akkermans, L. M. A., Rombouts, F. M., & Rijkers, G. T. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.04.008 · Cited by 116
Basu, S., Paul, D. K., Ganguly, S., Chatterjee, M., & Chandra, P. K. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31815a5780 · Cited by 117
“In 82% of these cases, patients had severe or fatal comorbidity.(36) In our study, no adverse effect of LGG was documented both during the hospital stay and during the follow-up period even in malnourished children.”
BackgroundMayrhofer, S., Domig, K. J., Mair, C., Zitz, U., Huys, G. R. B., & Kneifel, W. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02849-07 · Cited by 110
“Consequently, a broad variety of techniques have been reported for the in vitro susceptibility testing of lactobacilli (1, 2, 4, 12, 15, 22, 24, 25, 29).”
Sherid, M., Samo, S., Sulaiman, S., Husein, H., Sifuentes, H., & Sridhar, S. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0552-y · Cited by 108
Probiotics for the Prevention of Antibiotic-associated Diarrhea and Clostridium difficile Diarrhea
Katz, J. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00017 · Cited by 108
“Likewise, LGG and other lactobacilli have also been associated with bacteremia, particularly in patients with severe underlying illness.(50,51)”
BackgroundMeini, S., Laureano, R., Fani, L., Tascini, C., Galano, A., Antonelli, A., & Rossolini, G. M. (2015) · Infection · doi:10.1007/s15010-015-0798-2 · Cited by 106
Kochan, P., Chmielarczyk, A., Szymaniak, L., Brykczynski, M., Galant, K., Zych, A., Pakosz, K., Giedrys-Kalemba, S., Lenouvel, E., & Heczko, P. B. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03614.x · Cited by 104
Lau, S. K. P., Woo, P. C. Y., Fung, A. M. Y., Chan, K.-M., Woo, G. K. S., & Yuen, K. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45803-0 · Cited by 102
Salminen, M. K., Tynkkynen, S., Rautelin, H., Poussa, T., Saxelin, M., Ristola, M., Valtonen, V., & Järvinen, A. (2004) · HIV Clinical Trials · doi:10.1310/6f83-n39q-9ppp-lmvv · Cited by 103
Self-citationKlarin, B., Molin, G., Jeppsson, B. W., & Larsson, A. (2008) · Critical Care · doi:10.1186/cc7109 · Cited by 114
Slover, C. M., & Danziger, L. H. (2008) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2008.01.006 · Cited by 127
The administration of probiotics and synbiotics in immune compromised adults: is it safe?
van den Nieuwboer, M., Brummer, R. J., Guarner, F., Morelli, L., Cabana, M. D., & Claassen, E. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0079 · Cited by 110
Members of the Lactobacillus Genus Complex (LGC) as Opportunistic Pathogens: A Review
Rossi, F., Amadoro, C., & Colavita, G. (2019) · Microorganisms · doi:10.3390/microorganisms7050126 · Cited by 115
“The risk factors most commonly reported for Lactobacillus infections are diabetes mellitus, pre-existing structural heart disease (in infective endocarditis cases), cancer (especially leukemia), total parenteral nutrition, broad spectrum antibiotic therapy [39,40], chronic kidney disease, inflammatory bowel disease, p…”
BackgroundLactobacillus rhamnosus bacteremia: An emerging clinical entity
Gouriet, F., Million, M., Henri, M., Fournier, P.-E., & Raoult, D. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1599-5 · Cited by 93
“rhamnosus-associated bacteremia, the reported mortality rate ranges from 12 to 48 %, depending on the treatment [54, 55].”
Safe and efficacious probiotics: what are they?
Reid, G. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.06.006 · Cited by 113
“paracasei [20] and L. rhamnosus GG [ 12 ], demonstrate that a proportion of recipients of probiotics, howeversmall,doesseemtobeatriskofadverseeffects.The reasons for susceptibility in some individuals remain unclear.”
BackgroundSafety of probiotics: comparison of two popular strains
Hammerman, C., Bin‐Nun, A., & Kaplan, M. (2006) · BMJ · doi:10.1136/bmj.39010.630799.be · Cited by 100
Clostridium difficile-Associated Disease: Changing Epidemiology and Implications for Management
Owens, R. C. (2007) · Drugs · doi:10.2165/00003495-200767040-00001 · Cited by 89
Vesterlund, S., Vankerckhoven, V., Saxelin, M., Goossens, H., Salminen, S., & Ouwehand, A. C. (2007) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2007.02.002 · Cited by 110
Self-citationKiseleva, E. P., Mikhailopulo, K. I., Sviridov, O. V., Novik, G. I., Knirel, Y. A., & Dey, E. S. (2011) · Beneficial Microbes · doi:10.3920/bm2010.0011 · Cited by 93
“There are plenty of cases of sepsis induced by Lactobacillus (Arpi et al., 2003; Land et al., 2005; Salminen et al., 2004; Sullivan and Nord, 2006; Zein et al., 2008).”
BackgroundGenomic Diversity of Lactobacillus salivarius
Raftis, E. J., Salvetti, E., Torriani, S., Felis, G. E., & O’Toole, P. W. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01687-10 · Cited by 100
“barriers or defenses, rather than specialized “pathogenic strains,” as has been shown for other Lactobacillus species (52).”
Probiotics and irritable bowel syndrome
Dai, C., Zheng, C.-Q., Jiang, M., Ma, X.-Y., & Jiang, L.-J. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i36.5973 · Cited by 96
Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors
Seow, S. W., Cai, S., Rahmat, J. N., Bay, B., Lee, Y. K., Chan, Y. H., & Mahendran, R. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01426.x · Cited by 82
Clostridium difficile Infection in the Elderly
Keller, J. M., & Surawicz, C. M. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.10.008 · Cited by 84
The opportunistic nature of gut commensal microbiota
Dey, P., & Chaudhuri, S. R. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2133987 · Cited by 93
“Bacteraemia caused by probiotic L. rhamnosus could be associated with immunosuppressive drugs, prolonged episodes of hospitalisation, and prior surgical interventions (Salminen et al. 2004).”
BackgroundLactobacillus endocarditis: Case report and review of cases reported since 1992
Salvaña, E. M. T., & Frank, M. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.10.005 · Cited by 86
Probiotics: sorting the evidence from the myths
Pham, M., Lemberg, D. A., & Day, A. S. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01627.x · Cited by 88
Probiotic and synbiotic safety in infants under two years of age
van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F., & Brummer, R. J. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0046 · Cited by 84
“!) evaluating 89 cases of Lactobacillus bacteraemia (unrelated to probiotic intake) treatment with antimicrobials was effective both in vitro and in reducing mortality (odds ratio = 0.22; Salminen et al. , 2004).”
InfluentialProbiotics for infectious diseases: more drugs, less dietary supplementation
Kotzampassi, K. E., & Giamarellos‐Bourboulis, E. J. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.06.006 · Cited by 91
Probiotics in critically ill children
Singhi, S. C., & Kumar, S. (2016) · F1000Research · doi:10.12688/f1000research.7630.1 · Cited by 81
Safety Assessment of Two New Lactobacillus Strains as Probiotic for Human Using a Rat Model
Shokryazdan, P., Jahromi, M. F., Liang, J. B., Ramasamy, K., Sieo, C. C., & Ho, Y. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159851 · Cited by 78
Probiotics and down-regulation of the allergic response
Kalliomäki, M. A., & Isolauri, E. (2004) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2004.06.006 · Cited by 75
Cohen, S. A., Woodfield, M. C., Boyle, N., Stednick, Z., Boeckh, M., & Pergam, S. A. (2016) · Transplant Infectious Disease · doi:10.1111/tid.12587 · Cited by 75
“The same group went on to examine risk factors and outcomes for 89 patients with Lactobacillus bacteremia (21); most patients (82%) had severe comorbidities including gastrointestinal malignancy.”
Background(EFSA), E. F. S. A. (2008) · EFSA Journal · doi:10.2903/j.efsa.2008.923 · Cited by 75
Metadata
- Authors
- Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A.
- Affiliations
- Helsinki University Hospital (FI)
- University of Helsinki (FI)
- Valio (Finland) (FI)
- Corresponding author
- Salminen, Minna K.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01
- Volume
- 38
- Issue
- 1
- Pages
- 62-69
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141720872
- Cited by
- 426
- References
- 29
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 19 · 2023: 16 · 2022: 23 · 2021: 19 · 2020: 17 · 2019: 19 · 2018: 15 · 2017: 19 · 2016: 21 · 2015: 18 · 2014: 19 · 2013: 15 · 2012: 19
- FWCI
- 28.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- Lactobacillus rhamnosus GG, probiotics, mortality, comorbidities, immunosuppression, C-reactive protein, antimicrobial susceptibility, antimicrobial therapy
- MeSH terms
- Anti-Bacterial Agents, Female, Humans, Lactobacillus, Male, Middle Aged, Multivariate Analysis, Bacteremia, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.